JP2023500359A5 - - Google Patents
Info
- Publication number
- JP2023500359A5 JP2023500359A5 JP2022526371A JP2022526371A JP2023500359A5 JP 2023500359 A5 JP2023500359 A5 JP 2023500359A5 JP 2022526371 A JP2022526371 A JP 2022526371A JP 2022526371 A JP2022526371 A JP 2022526371A JP 2023500359 A5 JP2023500359 A5 JP 2023500359A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding portion
- cells
- azide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962930178P | 2019-11-04 | 2019-11-04 | |
| US62/930,178 | 2019-11-04 | ||
| PCT/US2020/058968 WO2021092080A1 (en) | 2019-11-04 | 2020-11-04 | Extracellular vesicles and uses thereof for antibody delivery |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023500359A JP2023500359A (ja) | 2023-01-05 |
| JP2023500359A5 true JP2023500359A5 (https=) | 2023-11-10 |
Family
ID=75848183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022526371A Pending JP2023500359A (ja) | 2019-11-04 | 2020-11-04 | 細胞外小胞、及び抗体の送達のためのその使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220409738A1 (https=) |
| EP (1) | EP4054631A4 (https=) |
| JP (1) | JP2023500359A (https=) |
| KR (1) | KR20230004424A (https=) |
| CN (1) | CN115942957A (https=) |
| WO (1) | WO2021092080A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023178500A1 (en) * | 2022-03-22 | 2023-09-28 | Beijing Theraxyte Bioscience Co. Ltd. | Therapeutic vesicles and methods of processing the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9149432B2 (en) * | 2010-03-19 | 2015-10-06 | Massachusetts Institute Of Technology | Lipid vesicle compositions and methods of use |
| EP3057662A4 (en) * | 2013-10-17 | 2017-03-29 | Children's Hospital Los Angeles | Antibody dependent exosome therapy |
| JP7075594B2 (ja) * | 2015-11-18 | 2022-05-26 | ユニバーシティ オブ ジョージア リサーチ ファウンデーション， インコーポレーテッド | 神経細胞の細胞外小胞 |
| US11458097B2 (en) * | 2016-03-30 | 2022-10-04 | The University Of North Carolina At Chapel Hill | Biological agent-exosome compositions and uses thereof |
| CA3093849A1 (en) * | 2018-03-23 | 2019-09-26 | Codiak Biosciences, Inc. | Extracellular vesicles comprising sting-agonist |
| US11519033B2 (en) * | 2018-08-28 | 2022-12-06 | 10X Genomics, Inc. | Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample |
| WO2020198626A1 (en) * | 2019-03-27 | 2020-10-01 | University Of Georgia Research Foundation, Inc. | Methods of making targeted vesicles, and compositions made thereby |
-
2020
- 2020-11-04 KR KR1020227017998A patent/KR20230004424A/ko active Pending
- 2020-11-04 CN CN202080091918.5A patent/CN115942957A/zh active Pending
- 2020-11-04 EP EP20885713.6A patent/EP4054631A4/en active Pending
- 2020-11-04 JP JP2022526371A patent/JP2023500359A/ja active Pending
- 2020-11-04 WO PCT/US2020/058968 patent/WO2021092080A1/en not_active Ceased
-
2022
- 2022-05-03 US US17/735,971 patent/US20220409738A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102712695B (zh) | 能够诱导细胞死亡的ror1生物抑制剂 | |
| AU2020200751A1 (en) | Universal chimeric antigen receptor expressing immune cells for targeting of diverse multiple antigens and method of manufacturing the same and use of the same for treatment of cancer, infections and autoimmune disorders | |
| EP3928790A1 (en) | Cd3 antigen binding fragment and application thereof | |
| TW201139666A (en) | Novel antibody having modification site introduced therein, and antibody fragment | |
| CN113056486B (zh) | 改善的抗flt3抗原结合蛋白 | |
| EP4279515A1 (en) | Fully human single-domain tandem chimeric antigen receptor (car) targeting cd5, and use thereof | |
| JP2025528068A (ja) | 血液脳関門を通過させるための組成物及び方法 | |
| JPWO2010109924A1 (ja) | Ｌｈ型二重特異性抗体 | |
| JP2022512922A (ja) | キメラ抗原受容体記憶様（ｃａｒｍｌ）ｎｋ細胞ならびにその産生および使用方法 | |
| JP2023515708A5 (https=) | ||
| WO2015172341A1 (zh) | 针对磷脂酰肌醇蛋白多糖-3和t细胞抗原的双特异性抗体 | |
| JP2023500359A5 (https=) | ||
| TW202340240A (zh) | 多特異性抗體及其藥物用途 | |
| KR102138998B1 (ko) | 제어성 t 세포의 활성화제 및 그의 사용 | |
| WO2022152282A1 (zh) | 抗人cd22的单克隆抗体及其用途 | |
| WO2025152667A1 (zh) | 抗人cd117单克隆抗体及其应用 | |
| US11767368B1 (en) | Antigen-binding protein and use thereof | |
| US9487585B2 (en) | Antibodies against 6-sulfo-LacNac-positive human dendritic cells, and their use | |
| KR20150015615A (ko) | 항체 및 핵산 결합 펩타이드를 포함하는 핵산 전달용 조성물 | |
| WO2024069165A1 (en) | Cll1 binding molecules | |
| EP4574839A1 (en) | Co-delivery system | |
| WO2023001155A1 (zh) | 一种磷脂酰肌醇蛋白聚糖3抗体及其应用 | |
| KR102470059B1 (ko) | 큰 핵산의 표적화된 세포내 전달 | |
| WO2025099252A1 (en) | Co-delivery system | |
| CN115181180B (zh) | 抗人程序性死亡配体-1（pd-l1）的抗体及其应用 |